trending Market Intelligence /marketintelligence/en/news-insights/trending/vsvgioxxenzafkjcghbsla2 content esgSubNav
In This List

McKesson fiscal Q4 EPS up YOY

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


McKesson fiscal Q4 EPS up YOY

McKesson Corp. said its adjusted earnings for the fiscal fourth quarter ended March 31 amounted to $3.49 per share, compared with the S&P Capital IQ consensus normalized EPS estimate of $3.57 per share.

EPS rose year over year from $3.41.

Adjusted earnings totaled $720.0 million on an aggregate basis, a decline from $730.0 million in the prior-year period.

Revenues climbed 6.0% on an annual basis to $51.63 billion from $48.71 billion.

On a GAAP basis, McKesson reported a loss of $1.15 billion, or $5.58 per share, compared with an income of $3.60 billion, or $16.79 per share, in the year-earlier period.

Fiscal 2018 results

For the year, the company's adjusted earnings per share totaled $12.62, compared with the S&P Capital IQ consensus normalized EPS estimate of $12.67.

EPS was $12.54 in the prior year.

Adjusted earnings were $2.64 billion on an aggregate basis, a fall from $2.80 billion in the prior year.

Full-year revenues increased year over year to $208.36 billion from $198.53 billion.

The company said GAAP earnings decreased 98.8% on an annual basis to $62.0 million, or 30 cents per share, from $5.19 billion, or $23.28 per share.

McKesson attributed the decrease in fiscal fourth-quarter and full-year GAAP earnings to noncash goodwill and long-lived asset impairment charges in the company's European and Canadian retail businesses. The medical supplier's prior-year results also included an after-tax net gain of $3 billion related to the creation of the Change Healthcare Holdings Inc. joint venture.

Fiscal 2019 guidance

McKesson expects adjusted EPS in the range of $13 to $13.80 for fiscal 2019.

Stock repurchase

In separate news, McKesson CEO John Hammergren said the company's board has authorized an additional $4 billion share repurchase program. The company repurchased approximately $1.7 billion of its stock during fiscal 2018.